DAT imaging with PET or SPECT, in fact, can be used to support or refute a diagnosis of dopamine-deficient parkinsonism in cases where this is unclear, with the implication of rationalizing a trial of dopamine therapy. Here, SLC6A3 is linked to Parkinson disease.